OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Medicine is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
	272
Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race	137
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	101
Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomics	95
Physical activity, polygenic risk score, and colorectal cancer risk	89
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes	81
Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model	80
Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet‐PHL‐C1 Protocol: Experience From a Resource‐Limited Country	78
Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC‐TFR Study	74
Clinicopathological features of adult T‐cell leukemia/lymphoma with T‐follicular helper phenotype	71
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis	70
Establishing a robust radioligand therapy program: A practical approach for North American centers	68
The Association Between Psychological Distress, Emergency Room Visits, and All‐Cause Mortality Among Colorectal Cancer Survivors	66
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	63
Impact of COVID‐19 on Time to Treat Breast Cancer and Racial Disparities Among Women in the Military Health System From FY2018‐2022	60
Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review	59
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy	55
Distinct Clinicopathological Features of HER2‐Negative, HER2‐Low, and HER2‐Overexpressing Urothelial Carcinoma in a Large Chinese Cohort	54
Explorative Detection of Fractional Exhaled Nitric Oxide (FeNO) in Exhaled Breath of Patients With Breast Cancer	54
Predicting Caregiver Anxiety and Depression From Patient Distress in Brain Tumor Dyads: Actor‐Partner Interdependence Model	54
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer	53
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II	52
Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON‐2 Retrospective Experience	51
Physical frailty deteriorates after a 5‐day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study	50
Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results	50

Renal toxicities in immune checkpoint inhibitors with or without chemotherapy: An observational, retrospective, pharmacovigilance study leveraging US FARES database	49
Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age–period–cohort modeling study	49
Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis	48
Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method	46
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Canc	46
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes	46
Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study	45
Issue Information	44
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer	44
Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment	44
Roles of long noncoding RNA in triple‐negative breast cancer	43
Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis	43
Cardiovascular Medication and Health Service Use in Individuals With Cancer: A Retrospective Population‐Based Cohort Study	43
Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis	43
Examining the involvement of guardians of children with acute lymphoblastic leukemia in Tanzania as public contributors to inform the design and conduct of the GuardiansCan project: A mixed	42
Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy	42
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population	41
Cuproptosis gene‐related, neural network‐based prognosis prediction and drug‐target prediction for KIRC	41
Issue Information	41